Royal DSM is a global purpose-led, science-based company founded in 1902 and listed on Euronext Amsterdam. We are a leader in health, nutrition and bioscience which, through our products and solutions, aims to address some of the world’s biggest challenges whilst creating profitable growth in order to simultaneously deliver economic, environmental and societal value for all.
01 Nov 2022
DSM’s trading update for the first nine months of 2022 is out now and our Health, Nutrition & Bioscience businesses all delivered good sales growth. Market demand remained resilient in what is a challenging macro-economic environment with the rising cost inflation.
02 Aug 2022
A good half year performance underpinned by resilient market demand.
02 Aug 2022
DSM announces that it pledges to purchase all of its electricity worldwide from renewable sources
Geraldine Matchett is Co-Chief Executive Officer, Chief Financial Officer and Member of the Managing Board. She was appointed as Co-CEO on 15 February 2020 and joined DSM’s Managing Board in 2014.
Dimitri de Vreeze is Co-Chief Executive Officer, Chief Operating Officer and Member of the Managing Board. He was appointed as Co-CEO on 15 February 2020 and joined DSM’s Managing Board in 2013.
DSM's Factbook provides investors and analysts with an introduction to the company and our key individual businesses.
DSM's share performance in real time and historically.
